Read News By Date

MONMOUTH JUNCTION, NJ, July 1, 2026 — Biotech Support Group (BSG) highlights the NuGel™ Glycoprotein Enrichment (PBA) Kit as an essential LC‑MS sample preparation method for enriching glycated and glycosylated synovial fluid proteins in osteoarthritis and osteoarthritis co‑existing with type 2 diabetes.
Read More

MONMOUTH JUNCTION, NJ, June 25, 2026 — Biotech Support Group (BSG) highlights Cleanascite™ lipid removal reagent cited in a Nature Metabolism study investigating how fibroblast-derived lipids drive tissue-specific squamous cell carcinoma invasion and epithelial-to-mesenchymal transition.
Read More

MONMOUTH JUNCTION, NJ, June 23, 2026 — Biotech Support Group (BSG)'s HemoVoid™ enrichment was featured in a 2026 Brain journal study on erythrocyte α‑synuclein transfer across the blood–brain barrier, advancing RBC proteomics for Parkinson's Disease research.
Read More

MONMOUTH JUNCTION, NJ, JUNE 11, 2026 — Biotech Support Group (BSG) highlights NRicher™ Platform's simplified and diversified approach to targeted proteomic enrichment, presented on Thursday, June 4 in the Proteomics: Quantitative II topic area at the 74th ASMS Conference in San Diego.
Read More

MONMOUTH JUNCTION, NJ, April 21, 2026 — Biotech Support Group (BSG), a pioneer in proteomics sample preparation, reports on the use of AlbuSorb™ in a sensing platform for comprehensive quality assessment of complex culture media in cell manufacturing.
Read More

MONMOUTH JUNCTION, NJ, March 18, 2026 — Biotech Support Group (BSG), a leader in proteomics sample preparation, highlights a recent study utilizing its proprietary lipid removal reagent, Cleanascite™, to investigate mechanisms of immunotherapy resistance in ovarian cancer omental metastases.
Read More

MONMOUTH JUNCTION, NJ, March 16, 2026 — Biotech Support Group (BSG), a pioneer in proteomics sample preparation, reports on the use of AlbuSorb™ PLUS in a groundbreaking study published in the European Journal of Pharmacology.
Read More

MONMOUTH JUNCTION, NJ, February 17, 2026 — A research team from Taipei Medical University, describes HemogloBind™ methods as advantageous in a proteomic comparison of lung and intestinal tissues from mice exposed to high temperature, low temperature, and high-to-low temperature groups.
Read More

MONMOUTH JUNCTION, NJ, February 17, 2026 — Biotech Support Group (BSG) reports on its proprietary lipid removal reagent, Cleanascite™, in a worm model study of signaling pathways that promote death avoidance, and thus, survival of conspecifics.
Read More

MONMOUTH JUNCTION, NJ, February 17, 2026 — An article led by researchers from The University of Burdwan, India utilized HemoVoid™ enrichment in a multi-omic study of thalassemia. The citation is: Mitra, Nibedita, et al. "Multi-omics analysis of red blood cells reveals thalassemia severity beyond globin gene mutations." Blood Advances (2026): bloodadvances-2025016677.
Read More

MONMOUTH JUNCTION, NJ, February 6, 2026 — Biotech Support Group (BSG) reports on its proprietary lipid removal reagent, Cleanascite™, as an essential method to assess the functional effects of circulating lipids after stroke.
Read More

MONMOUTH JUNCTION, NJ, January 29, 2026 — Biotech Support Group (BSG) reports on its proprietary lipid removal reagent, Cleanascite™, in a mouse model study of neuronal protein maintenance and the accumulation of protein aggregates with ageing.
Read More

MONMOUTH JUNCTION, NJ, January 19, 2026 — Biotech Support Group (BSG) reports on its NRicher™-derived product, AlbuVoid™, for secretome analysis of a human induced pluripotent stem cell (hiPSC)-derived product to promote successful reproductive outcomes.
Read More

MONMOUTH JUNCTION, NJ, January 5, 2026 – A research pre-print entitled “Ubiquitination and degradation of CD47 enhances macrophage phagocytosis of hemolytic erythrocytesâ€�, describes HemogloBind™ methods to advantage in a proteomic comparison of erythrocytes.
Read More